SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CVTX - CV Therapeutics, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mopgcw who wrote (222)6/29/2005 12:32:23 PM
From: mopgcw   of 411
 
Greedy batards: CV Therapeutics Files $55M Mixed Securities Shelf

DOW JONES NEWSWIRES
June 29, 2005 10:31 a.m.

--

WASHINGTON (Dow Jones)--CV Therapeutics Inc. (CVTX) filed to sell up to $55 million in mixed securities from time to time, according to a shelf filing Wednesday with the Securities and Exchange Commission.

CV Therapeutics said the mixed securities include common and preferred stock, debt securities, equity warrants and debt warrants.

The company didn't specify how it would use the net proceeds from the sale of the securities.

No underwriters were listed in the filing.

CV Therapeutics is a biopharmaceutical company.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext